| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.03 | 0.5 |